The store will not work correctly when cookies are disabled.
4-((2-(2-methyl-1H-imidazol-4-yl)imidazo[1,2-a]pyrazin-3-ylamino)methyl)benzonitrile
ID: ALA4558949
PubChem CID: 155557588
Max Phase: Preclinical
Molecular Formula: C18H15N7
Molecular Weight: 329.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc(-c2nc3cnccn3c2NCc2ccc(C#N)cc2)c[nH]1
Standard InChI: InChI=1S/C18H15N7/c1-12-21-10-15(23-12)17-18(25-7-6-20-11-16(25)24-17)22-9-14-4-2-13(8-19)3-5-14/h2-7,10-11,22H,9H2,1H3,(H,21,23)
Standard InChI Key: CTBJPPBOOAVSIB-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
36.1335 -13.6058 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.5461 -12.3348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8809 -12.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2154 -12.8216 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.9567 -13.6033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5039 -14.2161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3097 -14.0484 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.5656 -13.2625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0168 -12.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5448 -11.5097 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.0961 -12.5670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2587 -11.0961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8406 -11.7779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0155 -11.7783 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.7610 -12.5631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4287 -13.0477 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9764 -12.8186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2575 -10.2709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9704 -9.8597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9695 -9.0354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2539 -8.6231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5375 -9.0412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5420 -9.8641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2515 -7.7980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2491 -6.9729 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 5 2 0
4 2 1 0
2 3 2 0
3 1 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
2 10 1 0
3 11 1 0
10 12 1 0
11 13 2 0
13 14 1 0
14 15 1 0
15 16 2 0
16 11 1 0
15 17 1 0
12 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 25 3 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 329.37 | Molecular Weight (Monoisotopic): 329.1389 | AlogP: 2.91 | #Rotatable Bonds: 4 |
Polar Surface Area: 94.69 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.73 | CX Basic pKa: 5.90 | CX LogP: 1.11 | CX LogD: 1.09 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.60 | Np Likeness Score: -1.86 |
References
1. (2018) Inhibitors of trim33 and methods of use, |